Sexual health and function in liver disease.

Sexual dysfunction is highly prevalent in men with cirrhosis, with erectile dysfunction affecting the majority of male patients.

• Erectile dysfunction is reported in up to 50-70% of men with cirrhosis
• Hypogonadism is a key driver, resulting from disrupted hypothalamic-pituitary-gonadal axis function
• Elevated estrogen levels due to impaired hepatic metabolism contribute to feminizing effects and sexual dysfunction
• Portal hypertension and reduced penile blood flow are additional pathophysiological contributors

Women with cirrhosis experience high rates of sexual dysfunction including reduced libido, impaired arousal, and menstrual irregularities.

• Sexual dysfunction in women with cirrhosis is underrecognized and understudied compared to male patients
• Hormonal disruptions including altered estrogen and androgen levels contribute to dysfunction
• Menstrual irregularities and amenorrhea are common in women with advanced liver disease
• Fatigue, depression, and body image concerns related to cirrhosis symptoms (ascites, jaundice) further impair sexual function

The pathophysiology of sexual dysfunction in cirrhosis involves multiple interacting mechanisms including hormonal, vascular, neurological, and psychological factors.

• Cirrhosis disrupts the hypothalamic-pituitary-gonadal axis leading to hypogonadism in both sexes
• Impaired hepatic metabolism leads to altered sex hormone-binding globulin levels and sex hormone imbalances
• Zinc deficiency, which is common in cirrhosis, contributes to hypogonadism
• Systemic inflammation and sarcopenia associated with cirrhosis further impair sexual health
• Psychological comorbidities including depression and anxiety, which are prevalent in cirrhosis, are major contributors to sexual dysfunction

Common therapies used in cirrhosis management contribute to sexual dysfunction as a side effect.

• Spironolactone, widely used for ascites management, has antiandrogenic effects that can worsen sexual dysfunction and cause gynecomastia in men
• Beta-blockers used for portal hypertension prophylaxis are associated with erectile dysfunction
• Psychotropic medications used to treat hepatic encephalopathy or comorbid psychiatric conditions can impair sexual function
• The review highlights that medication review is an important clinical step in managing sexual dysfunction in cirrhosis patients

Liver transplantation partially improves sexual dysfunction but complete recovery occurs in only a relatively small percentage of patients.

• Liver transplantation can restore some hormonal abnormalities associated with cirrhosis
• Testosterone levels and gonadal function may improve post-transplant in some male patients
• Despite transplantation, many patients continue to experience sexual dysfunction due to persistent psychological, relational, and medication-related factors
• Immunosuppressive medications used post-transplant, including calcineurin inhibitors, can themselves contribute to sexual dysfunction
• Complete recovery of sexual function post-transplant occurs in only a relatively small percentage of patients

Sexual dysfunction in liver disease patients is underidentified in clinical settings due to lack of routine screening.

• The review provides validated tools for identifying sexual dysfunction in clinical settings
• Patient reluctance to discuss sexual health and clinician discomfort with the topic are identified barriers
• The review recommends proactive inquiry about sexual health as part of comprehensive cirrhosis management
• Standardized questionnaires can assist clinicians in identifying sexual dysfunction in both male and female patients

Several interventions exist to improve sexual health and functioning in patients with cirrhosis and liver transplant recipients.

• Phosphodiesterase-5 inhibitors (e.g., sildenafil) can be used for erectile dysfunction in cirrhotic men with appropriate caution
• Testosterone replacement therapy may be considered in hypogonadal male patients, though safety in cirrhosis requires careful consideration
• Switching from spironolactone to alternative diuretics (e.g., eplerenone) may reduce antiandrogenic side effects
• Psychological interventions including sex therapy and couples counseling are recommended components of management
• Multidisciplinary approaches addressing physical, hormonal, and psychological dimensions are emphasized

Reproductive dysfunction and fertility concerns are significant issues in patients with cirrhosis, particularly in women of childbearing age.

• Amenorrhea and anovulation reduce fertility in women with cirrhosis
• Pregnancy in women with cirrhosis carries significant risks and requires specialized management
• Post-liver transplant, menstrual function and fertility can recover, sometimes unexpectedly rapidly
• Contraception counseling is important for women of childbearing age post-transplant given the rapid return of fertility
• The teratogenic potential of immunosuppressive medications necessitates careful family planning discussions post-transplant